ProfileGDS5822 / ILMN_2742426
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 99% 96% 98% 98% 97% 99% 97% 97% 99% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 15069.799
GSM1276600PDAC Late Ablation Control 21349.296
GSM1276601PDAC Late Ablation Control 3339898
GSM1276602PDAC Late Ablation 12824.298
GSM1276603PDAC Late Ablation 2195197
GSM1276604PDAC Late Ablation 39099.599
GSM1303940PDAC Late Ablation_anti-CTLA4 12127.497
GSM1303941PDAC Late Ablation_anti-CTLA4 22417.697
GSM1303942PDAC Late Ablation_anti-CTLA4 34626.899